Fund shareholders of Sangamo Therapeutics Inc
ISIN US8006771062 · United States · LEI 2549006WMRKRC4G32Z67
- Fund shareholders
- 30
- Of which ETFs
- 7 23 other funds
- Value held
- 5.9M $
- Share of capital
- 5.0 % of 414.3M shares on Mar 25, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 7,956,969 | 2M $ | 0.00 % | 1.92 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 4,458,586 | 1.1M $ | 0.00 % | 1.08 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 1,782,998 | 770.8K $ | 0.00 % | 0.43 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 1,623,139 | 701.7K $ | 0.00 % | 0.39 % | as of Feb 28, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 881,181 | 105K $ | 0.00 % | 0.21 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 571,934 | 247.2K $ | 0.00 % | 0.14 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 478,526 | 206.9K $ | 0.00 % | 0.12 % | as of Feb 28, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 400,000 | 98.8K $ | 0.01 % | 0.10 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 324,542 | 80.1K $ | 0.00 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 300,000 | 35.8K $ | 0.00 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 251,256 | 108.6K $ | 0.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 244,820 | 105.8K $ | 0.20 % | 0.06 % | as of Feb 28, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 220,038 | 54.3K $ | 0.01 % | 0.05 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 186,285 | 46K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 164,888 | 19.7K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 146,442 | 17.5K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 143,289 | 61.9K $ | 0.44 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 122,707 | 53K $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 102,568 | 25.3K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 69,005 | 17K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 66,700 | 16.5K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 58,830 | 7K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 42,040 | 5K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 22,517 | 5.6K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 21,725 | 2.6K $ | 0.05 % | 0.01 % | as of Apr 30, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 7,828 | 1.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT CO | 7,208 | 859.2 $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 5,965 | 1.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 1,531 | 378 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 632 | 156 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.44 % | as of Feb 28, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 0.20 % | as of Feb 28, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 0.05 % | as of Apr 30, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 0.01 % | as of Mar 31, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 30 | +2 | 20,664,149 | +32.0 % |
| 2026Q1 | 28 | -3 | 15,650,533 | -0.1 % |
| 2025Q4 | 31 | -3 | 15,664,327 | -26.1 % |
| 2025Q3 | 34 | -5 | 21,190,237 | +2.9 % |
| 2025Q2 | 39 | -5 | 20,598,755 | -27.7 % |
| 2025Q1 | 44 | +6 | 28,484,051 | -10.2 % |
| 2024Q4 | 38 | -58 | 31,725,497 | -25.6 % |
| 2024Q3 | 96 | -25 | 42,666,560 | -6.2 % |
| 2024Q2 | 121 | -1 | 45,473,717 | +20.6 % |
| 2024Q1 | 122 | -16 | 37,719,412 | -15.1 % |
| 2023Q4 | 138 | 44,424,244 |
Institutional managers
107 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 40,400,067 | 10M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 6,270,441 | 1.5M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 5,288,097 | 1.3M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 4,570,862 | 1.1M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 4,547,848 | 1.1M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 3,836,665 | 947.3K $ | as of Mar 31, 2026 |
| UBS Group AG | 2,570,992 | 635K $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,352,360 | 580.8K $ | as of Mar 31, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,050,384 | 506.2K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,838,390 | 452.2K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,694,783 | 418.4K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,687,463 | 416.6K $ | as of Mar 31, 2026 |
| LUMINUS MANAGEMENT LLC | 1,681,089 | 415.1K $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 1,218,671 | 300.9K $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,045,232 | 258.1K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 737,867 | 182.2K $ | as of Mar 31, 2026 |
| HighTower Advisors, LLC | 706,481 | 174.4K $ | as of Mar 31, 2026 |
| SANDERS MORRIS HARRIS LLC | 668,000 | 164.9K $ | as of Mar 31, 2026 |
| MAK CAPITAL ONE LLC | 561,538 | 138.6K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 423,265 | 104.5K $ | as of Mar 31, 2026 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 400,000 | 99K $ | as of Mar 31, 2026 |
| CANADA PENSION PLAN INVESTMENT BOARD | 397,100 | 98K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 377,287 | 93.2K $ | as of Mar 31, 2026 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 361,277 | 89.2K $ | as of Mar 31, 2026 |
| Diametric Capital, LP | 353,477 | 87.3K $ | as of Mar 31, 2026 |
Declared shareholders of Sangamo Therapeutics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Armistice Capital, LLC and 1 other | 9.75 % | 40,400,067 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Sangamo Therapeutics Inc". https://titelia.com/en/stocks/sangamo-therapeutics-inc-US8006771062